← Leaderboards
Zhiqiang Lin
Masonic Medical Research Laboratory, Inc
$2,991,840
Attributed
$2,991,840
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $646.3K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,991,840 · 2
By mechanism
R01$2,549,340 · 1
R56$442,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Loss Of Function”
- James Dale Berry · Brigham And Women'S Hospital$10,098,517
- Mary E Hamby · Cognition Therapeutics, Inc.$9,832,688
- Balasubramani K Goundappa · University Of Pittsburgh At Pittsburgh$8,538,627
- Jessica Alber · University Of Rhode Island$8,348,817
- Leonard Freedman · Leidos Biomedical Research, Inc.$7,846,961
- Tony Yuen · Icahn School Of Medicine At Mount Sinai$7,796,691
Research focus
Loss Of FunctionSignal TransductionHeart DiseasesIn VivoPathway InteractionsRegulationGenetic TranscriptionHeartHeart FailureHeart InjuriesMolecularMyocardial InfarctionBindingCardiogenesisAdultChronicGrowthCellsCardiacGenesCessation Of LifeHeart FunctionCardiac MyocytesStress
Grant awards (6)
YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses$637,407
R01 · FY2025 · HL · contact PI
YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses$624,659
R01 · FY2024 · HL · contact PI
YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses$646,307
R01 · FY2023 · HL · contact PI
YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses$640,967
R01 · FY2022 · HL · contact PI
VGLL4 and IRF2BP2 regulation of cardiomyocyte survival and hypertrophy$250,235
R56 · FY2017 · HL · contact PI
VGLL4 and IRF2BP2 regulation of cardiomyocyte survival and hypertrophy$192,265
R56 · FY2017 · HL · contact PI